Abstract
BackgroundIn patients with active RA and inadequate response to several lines of biologics including TNF blockers and RTX, there is no recommendation for therapeutic strategy. It has been suggested that...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
